» Researchers Find Promising New Treatments for PTSD Indicates David Magann, Tampa Veteran’s Attorney

Researchers Find Promising New Treatments for PTSD Indicates David Magann, Tampa Veteran’s Attorney

Tampa, FL (Law Firm Newswire) January 27, 2014 - A new mental-health “vaccine” treatment and an accelerated therapy technique have been discovered to better treat Post Traumatic Stress Disorder (PTSD).

The results of two studies, one from Florida and one from Massachusetts, were both released in December. Each offers hope for improvement to current methods used to combat PTSD. The developments are likely to prove especially welcome amongst war veterans, one of the communities hit hardest by PTSD in the United States.

The Florida study has found that a technique called Accelerated Resolution Therapy (ART), a combination of evidence-based psychotherapies and controlled eye movements, results in a shorter intervention period for the treatment of PTSD. Just as promisingly, it appears to offer a much better chance of completion than conventional forms of therapy do.

ART works first through vocal therapy and a series of patient rapid-eye movements. Clinicians aim to minimize sensations — including tightening of the chest, increased heart rate and sweating — that are triggered by visualization of a prior traumatic experience. Thereafter, ART seeks to “replace” these stressful images with positive ones in a manner that renders the stressful images inaccessible.

Trials for ART were conducted by enlisting 57 service members and veterans, most of whom were from the Tampa Bay region.

“Accelerated resolution therapy is giving hope to many veterans who felt like they had no hope,” said retired Lt. Col. Lawrence A. Braue, Ed.D., director of the University of South Florida Office of Veterans Services. “I look forward to the day when this treatment is widely available across the country.”

Meanwhile, another discovery could help veterans fight PTSD on a preclusive level. Researchers at the Massachusetts Institute of Technology (MIT) may have found a way to create a “vaccine” to prevent PTSD.

Clinical studies at MIT focused on ghrelin, a rather obscure hormone produced by the stomach. Researchers turned their attention to the hormone after finding that increased levels of stress cause the stomach to secrete larger amounts.

In experiments, researchers administered a drug that stimulated ghrelin secretion among rats, which made the rodents more susceptible to fear. However, fear levels dropped when the researchers then blocked receptors for the hormone.

The MIT research has moved forward to a clinical trial in collaboration with Massachusetts General Hospital (MGH). And the MIT researchers hold hope that blocking ghrelin could be useful even in cases where people have already been traumatized, which would greatly broaden the applicability of the treatment.

“This could represent a place where, with medication, we could help people undo the effects of pretty severe exposures to difficult social situations, so it could be very promising, said Dr. Mireya Nadal-Vicens of the Center for Anxiety and Traumatic Stress Disorders at MGH. “It could be something that we think about for all sorts of individuals at risk and seeing whether we can produce long-term or intergenerational effects.”

David W. Magann, P.A.
Main Office:
156 W. Robertson St.
Brandon, FL 33511
Call: (813) 657-9175

Tampa Office:
4012 Gunn Highway #165
Tampa, Florida 33618

View Larger Map

  • Veterans Statistics At A Glance
    Gulf War Veterans, Persian Gulf War, The Global War on Terror (GWOT), Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), Operation Freedom’s Sentinel (OFS) and ongoing conflicts : Gulf War-era II veterans served on active duty in the U.S. Armed Forces any time since September 2001. In 2015, there were 3.6 million veterans who had served during Gulf War Era II. U.S. combat operations in Afghanistan ended on December 31, 2014. As part of Operation FREEDOM’S SENTINEL (OFS), U.S. forces remain in the country to participate in a coalition mission to train, advise, and assist Afghan National Defense and Security […]
  • Agent Orange Claims
    The VA’s general regulations implementing the laws related to Agent Orange are found at 38 C.F.R. § 3.307. Also, specific provisions relating to Agent Orange are found at 38 U.S.C. § 1116. In essence, specific medical conditions are presumed to be related to exposure to Agent Orange in service. The claim will still need to be supported by an adequate medical diagnosis of the condition and proof of those requirements for service location(s) as outlined below. Generally, veterans who served in the Country of Vietnam are presumed to have been exposed, but other types of exposure may require direct proof. […]
  • Camp Lejeune: Water Contamination Update, Presumptive Conditions
    From the 1950s through the 1980s, people living or working at the U.S. Marine Corps Base Camp Lejeune, North Carolina, were potentially exposed to drinking water contaminated with industrial solvents, benzene, and other chemicals. VA has established a presumptive service connection for Veterans, Reservists, and National Guard members exposed to contaminants in the water supply at Camp Lejeune from August 1, 1953 through December 31, 1987 who later developed one of the following eight diseases: Adult leukemia Aplastic anemia and other myelodysplastic syndromes Bladder cancer Kidney cancer Liver cancer Multiple myeloma Non-Hodgkin’s lymphoma Parkinson’s disease Presently, these conditions are the only […]

See other news sources publishing this article. BETA | Tags: , , , , ,

Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required